Skip to main content
ONC logo

ONC · BeOne Medicines Ltd. · Holdings

Track ONC — free
$402.41 -1.19 (-0.29%) Play latest call Q2 2026 earnings call transcript
Market Cap
$46.10B
Shares
114.23M
Volume · Nov 19 18.66K Avg daily vol (3M) 392.03K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 327
Total Value: $13,380,641,344
Total Shares: 36,707,573
Showing 1–100 of 335 holdings by value · page 1 of 4

Institutional Ownership Trend

27 quarters

Holder Concentration

Share of 13F common-share value, across 327 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
24.2%
Dec 2023 → Sep 2026 · range 20.7% – 26.7%
−1.1 pts
Top 5
67.2%
Dec 2023 → Sep 2026 · range 61.2% – 73.8%
+1.9 pts
Top 10
76.5%
Dec 2023 → Sep 2026 · range 76.2% – 87.3%
−1.0 pts
HHI
1,109
Dec 2023 → Sep 2026 · range 924 – 1,373
Broadly held−21

Who Holds ONC

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 323 filers, like-for-like change +5.0%; actively managed books +4.6%; index-like books +10.9%.

Holder type Share Filers Change
Registered adviser 52.2% 168 +0.3%
Exempt adviser 0.1% 2 -85.2%
Adviser 24.1% 13 +31.2%
Bank 3.3% 18 +11.5%
Broker-dealer 0.0% 2 +70.7%
Benefit plan 0.0% 1 0.0%
Non-US 1.3% 8 +46.8%
Holding company 12.1% 11 -10.2%
Insurer 0.0% 0 —
Unknown 6.9% 100 +0.8%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 1 holder with no observed 2026-06-30 13F and 4 holders with no observed 2026-09-30 13F.

Conviction and Crowding

323 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
6
1.86% of filers hold it in their top 10
Jun 30, 2026: 5
Holders above 5%
1
median weight 0.006%
Jun 30, 2026: 1
Crowding
0.944%
of shares outstanding, 5th percentile
Jun 30, 2026: 0.977%
Private-fund advisers
0.939%
of shares outstanding
Institutional ownership
2.48%
2.59% of the estimated free float
Top 10 holders
76.2%
of 13F shares, Herfindahl 0.110
Active holders
+4.6%
like-for-like share change of active filers
5% stakes on record
1
1 13D, 0 13G
How long holders have held it value-weighted 21.0 quarters
Under 1 year 12.9% 1 to 3 years 12.4% 3 years or more 74.8% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $138,711,498 (20 buying, 14 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$312.35
estimated per share
Jun 30, 2026: $290.10
Quarter-end price
$364.52
implied by 13F values
Estimated gain or loss
+16.7%
price against the estimated cost
Estimated at a loss
0.000%
of costed 13F value

Estimated cost covers 24.2% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies ONC's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 BNTX BioNTech SE 11
2 HTHT H World Group Ltd 6
3 ELVN Enliven Therapeutics, Inc. 7
4 LBRX Lb Pharmaceuticals Inc 5
5 TCOM Trip.com Group Ltd 7
6 TNGX Tango Therapeutics, Inc. 7
7 ARGX Argenx SE 10
8 RVMD Revolution Medicines, Inc. 12
9 INSM INSMED Inc 9
10 SYRE Spyre Therapeutics, Inc. 6

Shareholder Targets

13F filers that own its peers but not ONC, quarter ended Sep 30, 2026

Found through its holder-overlap peers: BNTX, HTHT, ELVN, LBRX, TCOM, TNGX, ARGX, RVMD, INSM, SYRE, ALNY, ROIV, IBN, DMRA, RYAAY, IDYA, SRRK, EWTX, COGT, KOD. 1,436 filers in all.

# Filer In peers
1 VANGUARD CAPITAL MANAGEMENT LLC Registered adviser, Index-like $6,978,785,644 15 held
2 JANUS HENDERSON GROUP PLC Adviser, Diversified active $6,610,354,882 17 held
3 VANGUARD PORTFOLIO MANAGEMENT LLC Registered adviser, Diversified active $6,311,392,453 15 held
4 FARALLON CAPITAL MANAGEMENT LLC Registered adviser, Diversified active $3,693,489,299 5 held
5 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $3,038,043,241 6 held
6 Capital Research Global Investors Adviser, Diversified active $2,923,493,543 6 held
7 Paradigm Biocapital Advisors LP Registered adviser, Concentrated $2,592,448,196 5 held
8 Darwin Global Management, Ltd. Exempt adviser, Concentrated $2,428,626,024 2 held
9 RTW INVESTMENTS, LP Registered adviser, Diversified active $1,929,965,307 6 held
10 Orbis Allan Gray Ltd Unknown, Diversified active $1,659,580,363 3 held

Fund Ownership of ONC by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 0.78% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.02% 25,154
Index ETFs 0.76% 868,596
Active ETFs 0.15% 166,077
Active funds 7.68% 8,775,088
Unclassified 0.02% 18,915
All registered funds 8.63% 9,853,830
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
71
Increased
132
Decreased
74
Sold Out
26
Unchanged
49

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +42
Institutional value: +34.7%
Shares held: +5.0%

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 335
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 335 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1651308 CUSIP 07725L102 13F (30d) 333 filings 303 filers Visit website Investor relations